» Articles » PMID: 22183742

Fibulin-1 is Required During Cardiac Ventricular Morphogenesis for Versican Cleavage, Suppression of ErbB2 and Erk1/2 Activation, and to Attenuate Trabecular Cardiomyocyte Proliferation

Overview
Journal Dev Dyn
Publisher Wiley
Date 2011 Dec 21
PMID 22183742
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Trabeculation is an integral component of cardiac ventricular morphogenesis and is dependent on the matrix metalloproteinase, ADAMTS1. A substrate of ADAMTS1 is the proteoglycan versican which is expressed in the developing ventricle and which has been implicated in trabeculation. Fibulin-1 is a versican and ADAMTS1-binding extracellular matrix protein required for ventricular morphogenesis. Here we investigated the involvement of fibulin-1 in ADAMTS1-mediated cleavage of versican in vitro, and the involvement of fibulin-1 in versican cleavage in ventricular morphogenesis.

Results: We show that fibulin-1 is a cofactor for ADAMTS1-dependent in vitro cleavage of versican V1, yielding a 70-kDa amino-terminal fragment. Furthermore, fibulin-1-deficiency in mice was found to cause a significant reduction (>90%) in ventricular levels of the 70-kDa versican V1 cleavage product and a 2-fold increase in trabecular cardiomyocyte proliferation. Decreased versican V1 cleavage and augmented trabecular cardiomyocyte proliferation in fibulin-1 null hearts is accompanied by increased ventricular activation of ErbB2 and Erk1/2. By contrast, versican deficiency was found to lead to decreased cardiomyocyte proliferation and reduced ventricular trabeculation.

Conclusion: We conclude that fibulin-1 regulates versican-dependent events in ventricular morphogenesis by promoting ADAMTS1 cleavage of versican leading to suppression of trabecular cardiomyocyte proliferation mediated by the ErbB2-Map kinase pathway.

Citing Articles

Fibulin-1 promotes intimal hyperplasia after venous stent implantation through ACE mediated angiotensin II signaling.

Gao Y, Chen T, Hong L Heliyon. 2024; 10(7):e27626.

PMID: 38560238 PMC: 10979058. DOI: 10.1016/j.heliyon.2024.e27626.


Exploring the cardiac ECM during fibrosis: A new era with next-gen proteomics.

Sarohi V, Chakraborty S, Basak T Front Mol Biosci. 2022; 9:1030226.

PMID: 36483540 PMC: 9722982. DOI: 10.3389/fmolb.2022.1030226.


Defining the versican interactome in lung health and disease.

Tang F, Brune J, Chang M, Reeves S, Altemeier W, Frevert C Am J Physiol Cell Physiol. 2022; 323(2):C249-C276.

PMID: 35649251 PMC: 9291419. DOI: 10.1152/ajpcell.00162.2022.


ADAMTS Proteins and Vascular Remodeling in Aortic Aneurysms.

Mougin Z, Huguet Herrero J, Boileau C, Le Goff C Biomolecules. 2022; 12(1).

PMID: 35053160 PMC: 8773774. DOI: 10.3390/biom12010012.


Targeting cardiomyocyte proliferation as a key approach of promoting heart repair after injury.

Li S, Ma W, Cai B Mol Biomed. 2022; 2(1):34.

PMID: 35006441 PMC: 8607366. DOI: 10.1186/s43556-021-00047-y.


References
1.
Kern C, Wessels A, McGarity J, Dixon L, Alston E, Argraves W . Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies. Matrix Biol. 2010; 29(4):304-16. PMC: 2862783. DOI: 10.1016/j.matbio.2010.01.005. View

2.
Aspberg A, Adam S, Kostka G, Timpl R, Heinegard D . Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J Biol Chem. 1999; 274(29):20444-9. DOI: 10.1074/jbc.274.29.20444. View

3.
Nakamura T, Colbert M, Krenz M, Molkentin J, Hahn H, Dorn 2nd G . Mediating ERK 1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome. J Clin Invest. 2007; 117(8):2123-32. PMC: 1913487. DOI: 10.1172/JCI30756. View

4.
Porter S, Clark I, Kevorkian L, Edwards D . The ADAMTS metalloproteinases. Biochem J. 2004; 386(Pt 1):15-27. PMC: 1134762. DOI: 10.1042/BJ20040424. View

5.
King T, Bland Y, Webb S, Barton S, Brown N . Expression of Peg1 (Mest) in the developing mouse heart: involvement in trabeculation. Dev Dyn. 2002; 225(2):212-5. DOI: 10.1002/dvdy.10142. View